Yale School of Medicine: Study Hints at How Cancer Immunotherapy Can Be Safer
June 21, 2023
June 21, 2023
NEW HAVEN, Connecticut, June 21 (TNSjou) -- Yale School of Medicine issued the following news:
Cancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumors. Immunotherapies that block checkpoint receptors like PD-1, proteins that limit the capacity of T cells to attack tumors, have become the choice for the treatment of numerous types of solid cancer.
However, the introduction of PD-1-blocking agents c . . .
Cancer immunotherapy has revolutionized treatment of many forms of cancer by unleashing the immune system response against tumors. Immunotherapies that block checkpoint receptors like PD-1, proteins that limit the capacity of T cells to attack tumors, have become the choice for the treatment of numerous types of solid cancer.
However, the introduction of PD-1-blocking agents c . . .